Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Effect of curcumin on diabetic peripheral neuropathic pain: possible involvement of opioid system.

Banafshe HR, Hamidi GA, Noureddini M, Mirhashemi SM, Mokhtari R, Shoferpour M.

Eur J Pharmacol. 2014 Jan 15;723:202-6. doi: 10.1016/j.ejphar.2013.11.033.

PMID:
24315931
2.

Curcumin attenuates diabetic neuropathic pain by downregulating TNF-α in a rat model.

Li Y, Zhang Y, Liu DB, Liu HY, Hou WG, Dong YS.

Int J Med Sci. 2013;10(4):377-81. doi: 10.7150/ijms.5224.

3.

Possible mechanism of protective effect of thalidomide in STZ-induced-neuropathic pain behavior in rats.

Taliyan R, Sharma PL.

Inflammopharmacology. 2012 Apr;20(2):89-97. doi: 10.1007/s10787-011-0106-4.

PMID:
22179948
4.

Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: descending monoamine system and opioid receptors are differentially involved.

Zhao X, Xu Y, Zhao Q, Chen CR, Liu AM, Huang ZL.

Neuropharmacology. 2012 Feb;62(2):843-54. doi: 10.1016/j.neuropharm.2011.08.050.

PMID:
21945716
5.

The stem bark extracts of Cenostigma macrophyllum attenuates tactile allodynia in streptozotocin-induced diabetic rats.

Piaulino CA, Carvalho FC, Almeida BC, Chaves MH, Almeida FR, Brito SM.

Pharm Biol. 2013 Oct;51(10):1243-8. doi: 10.3109/13880209.2013.786096.

PMID:
23844576
6.

Lithium attenuates pain-related behavior in a rat model of neuropathic pain: possible involvement of opioid system.

Banafshe HR, Mesdaghinia A, Arani MN, Ramezani MH, Heydari A, Hamidi GA.

Pharmacol Biochem Behav. 2012 Jan;100(3):425-30. doi: 10.1016/j.pbb.2011.10.004.

PMID:
22009032
7.

Passiflora incarnata attenuation of neuropathic allodynia and vulvodynia apropos GABA-ergic and opioidergic antinociceptive and behavioural mechanisms.

Aman U, Subhan F, Shahid M, Akbar S, Ahmad N, Ali G, Fawad K, Sewell RD.

BMC Complement Altern Med. 2016 Feb 24;16:77. doi: 10.1186/s12906-016-1048-6.

8.

Enhancement of antinociceptive effect of morphine by antidepressants in diabetic neuropathic pain model.

Cegielska-Perun K, Bujalska-Zadrożny M, Gąsińska E, Makulska-Nowak HE.

Pharmacol Rep. 2014 Apr;66(2):228-34. doi: 10.1016/j.pharep.2013.09.003.

PMID:
24911074
9.

Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain.

Christoph T, De Vry J, Tzschentke TM.

Neurosci Lett. 2010 Feb 12;470(2):91-4. doi: 10.1016/j.neulet.2009.12.020.

PMID:
20026182
10.

Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats.

Ulugol A, Karadag HC, Tamer M, Firat Z, Aslantas A, Dokmeci I.

Neurosci Lett. 2002 Aug 9;328(2):129-32.

PMID:
12133572
11.

Antinociceptive effect of intrathecal administration of taurine in rat models of neuropathic pain.

Terada T, Hara K, Haranishi Y, Sata T.

Can J Anaesth. 2011 Jul;58(7):630-7. doi: 10.1007/s12630-011-9504-8.

PMID:
21512835
12.

Mechanical hyperalgesia in rats with diabetic polyneuropathy is selectively inhibited by local peripheral nociceptin/orphanin FQ receptor and µ-opioid receptor agonism.

Schiene K, Tzschentke TM, Schröder W, Christoph T.

Eur J Pharmacol. 2015 May 5;754:61-5. doi: 10.1016/j.ejphar.2015.01.049.

PMID:
25697471
13.

Spinal orexin-1 receptors mediate anti-hyperalgesic effects of intrathecally-administered orexins in diabetic neuropathic pain model rats.

Kajiyama S, Kawamoto M, Shiraishi S, Gaus S, Matsunaga A, Suyama H, Yuge O.

Brain Res. 2005 May 17;1044(1):76-86.

PMID:
15862792
14.

Long-Term Antihyperalgesic and Opioid-Sparing Effects of 5-Day Ketamine and Morphine Infusion ("Burst Ketamine") in Diabetic Neuropathic Rats.

Mak P, Broadbear JH, Kolosov A, Goodchild CS.

Pain Med. 2015 Sep;16(9):1781-93. doi: 10.1111/pme.12735.

PMID:
25800174
16.

Antihyperalgesic and antiallodynic effects of mianserin on diabetic neuropathic pain: a study on mechanism of action.

Üçel Uİ, Can ÖD, Demir Özkay Ü, Öztürk Y.

Eur J Pharmacol. 2015 Jun 5;756:92-106. doi: 10.1016/j.ejphar.2015.02.048.

PMID:
25771454
17.

Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy.

Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL.

Fitoterapia. 2012 Jun;83(4):650-9. doi: 10.1016/j.fitote.2012.01.010.

PMID:
22343014
18.

6-Methoxyflavanone attenuates mechanical allodynia and vulvodynia in the streptozotocin-induced diabetic neuropathic pain.

Akbar S, Subhan F, Karim N, Shahid M, Ahmad N, Ali G, Mahmood W, Fawad K.

Biomed Pharmacother. 2016 Dec;84:962-971. doi: 10.1016/j.biopha.2016.10.017.

PMID:
27764759
19.

A streptozotocin-induced diabetic neuropathic pain model for static or dynamic mechanical allodynia and vulvodynia: validation using topical and systemic gabapentin.

Ali G, Subhan F, Abbas M, Zeb J, Shahid M, Sewell RD.

Naunyn Schmiedebergs Arch Pharmacol. 2015 Nov;388(11):1129-40. doi: 10.1007/s00210-015-1145-y.

20.

Pharmacological characterization of different fractions of Calotropis procera (Asclepiadaceae) in streptozotocin induced experimental model of diabetic neuropathy.

Yadav SK, Nagori BP, Desai PK.

J Ethnopharmacol. 2014 Mar 14;152(2):349-57. doi: 10.1016/j.jep.2014.01.020.

PMID:
24486599
Items per page

Supplemental Content

Support Center